Literature DB >> 12446679

Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites.

Monica Borgatti1, Ilaria Lampronti, Alessandra Romanelli, Carlo Pedone, Michele Saviano, Nicoletta Bianchi, Carlo Mischiati, Roberto Gambari.   

Abstract

Peptide nucleic acids (PNAs) are DNA-mimicking molecules in which the sugar-phosphate backbone is replaced by a pseudopeptide backbone composed of N-(2-aminoethyl)glycine units. We determined whether double-stranded molecules based on PNAs and PNA-DNA-PNA (PDP) chimeras could be capable of stable interactions with nuclear proteins belonging to the Sp1 transcription factor family and, therefore, could act as decoy reagents able to inhibit molecular interactions between Sp1 and DNA. Since the structure of PNA/PNA hybrids is very different from that of the DNA/DNA double helix, they could theoretically alter the molecular structure of the double-stranded PNA-DNA-PNA chimeras, perturbing interactions with specific transcription factors. We found that PNA-based hybrids do not inhibit Sp1/DNA interactions. In contrast, hybrid molecules based on PNA-DNA-PNA chimeras are very effective decoy molecules, encouraging further experiments focused on the possible use of these molecules for the development of potential agents for a decoy approach in gene therapy. In this respect, the finding that PDP-based decoy molecules are more resistant than DNA/DNA hybrids to enzymatic degradation appears to be of great interest. Furthermore, their resistance can even be improved after complexation with cationic liposomes to which PDP/PDP chimeras are able to bind by virtue of their internal DNA structure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446679     DOI: 10.1074/jbc.M206780200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Interaction of HMG proteins and H1 with hybrid PNA-DNA junctions.

Authors:  Filbert Totsingan; Anthony J Bell
Journal:  Protein Sci       Date:  2013-09-18       Impact factor: 6.725

2.  Engineered Hematopoietic Stem Cells as Therapeutics for Hemophilia A.

Authors:  Philip M Zakas; H Trent Spencer; Christopher B Doering
Journal:  J Genet Syndr Gene Ther       Date:  2011-11-16

3.  Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β0-Thalassemia Families with High Fetal Hemoglobin Levels.

Authors:  Nicoletta Bianchi; Lucia Carmela Cosenza; Ilaria Lampronti; Alessia Finotti; Giulia Breveglieri; Cristina Zuccato; Enrica Fabbri; Giovanni Marzaro; Adriana Chilin; Gioia De Angelis; Monica Borgatti; Cristiano Gallucci; Cecilia Alfieri; Michela Ribersani; Antonella Isgrò; Marco Marziali; Javid Gaziev; Aldo Morrone; Pietro Sodani; Guido Lucarelli; Roberto Gambari; Katia Paciaroni
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

4.  Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity.

Authors:  Rita Crinelli; Marzia Bianchi; Lucia Gentilini; Linda Palma; Mads D Sørensen; Torsten Bryld; Ravindra B Babu; Khalil Arar; Jesper Wengel; Mauro Magnani
Journal:  Nucleic Acids Res       Date:  2004-03-29       Impact factor: 16.971

Review 5.  DNA triple helices: biological consequences and therapeutic potential.

Authors:  Aklank Jain; Guliang Wang; Karen M Vasquez
Journal:  Biochimie       Date:  2008-02-21       Impact factor: 4.079

6.  Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221.

Authors:  Eleonora Brognara; Enrica Fabbri; Elena Bazzoli; Giulia Montagner; Claudio Ghimenton; Albino Eccher; Cinzia Cantù; Alex Manicardi; Nicoletta Bianchi; Alessia Finotti; Giulia Breveglieri; Monica Borgatti; Roberto Corradini; Valentino Bezzerri; Giulio Cabrini; Roberto Gambari
Journal:  J Neurooncol       Date:  2014-03-05       Impact factor: 4.130

7.  Characterization of the structural and protein recognition properties of hybrid PNA-DNA four-way junctions.

Authors:  Douglas Iverson; Crystal Serrano; Ann Marie Brahan; Arik Shams; Filbert Totsingan; Anthony J Bell
Journal:  Arch Biochem Biophys       Date:  2015-09-05       Impact factor: 4.013

8.  Myocyte enhancer factor 2 activates promoter sequences of the human AbetaH-J-J locus, encoding aspartyl-beta-hydroxylase, junctin, and junctate.

Authors:  Giordana Feriotto; Alessia Finotti; Pompeo Volpe; Susan Treves; Stefano Ferrari; Cecilia Angelelli; Francesco Zorzato; Roberto Gambari
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

9.  Effects of decoy molecules targeting NF-kappaB transcription factors in Cystic fibrosis IB3-1 cells: recruitment of NF-kappaB to the IL-8 gene promoter and transcription of the IL-8 gene.

Authors:  Alessia Finotti; Monica Borgatti; Valentino Bezzerri; Elena Nicolis; Ilaria Lampronti; Maria Dechecchi; Irene Mancini; Giulio Cabrini; Michele Saviano; Concetta Avitabile; Alessandra Romanelli; Roberto Gambari
Journal:  Artif DNA PNA XNA       Date:  2012-04-01

10.  Inhibitory Effects of Bangladeshi Medicinal Plant Extracts on Interactions between Transcription Factors and Target DNA Sequences.

Authors:  Ilaria Lampronti; Mahmud T H Khan; Monica Borgatti; Nicoletta Bianchi; Roberto Gambari
Journal:  Evid Based Complement Alternat Med       Date:  2008-09       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.